Vivanza Biosciences Limited (BOM:530057)

Vivanza Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	6.01	1.17	1.67	1.41	0.55	-30.93
Short-Term Investments	-	0.3	0.29	0.29	0.01	-
Cash & Short-Term Investments	6.01	1.47	1.96	1.7	0.56	-30.93
Cash Growth	251.17%	-25.03%	15.11%	203.21%	-	-
Accounts Receivable	346.78	80.59	115.39	124.79	78.4	62.51
Receivables	364.86	97.03	131.62	166.11	97.69	73.05
Inventory	48.75	22.63	20.06	24.75	24.28	6.54
Other Current Assets	38.2	2.72	3.77	2.98	1.98	1.48
Total Current Assets	457.82	123.84	157.41	195.54	124.51	50.15
Property, Plant & Equipment	6.92	6.99	7.05	6.8	6.82	6.9
Long-Term Investments	0.03	0.03	0.03	0.03	0.03	0.03
Goodwill	16.05	16.05	16.05	16.05	16.05	16.05
Other Intangible Assets	0.3	0.3	0.3	0.3	0.3	0.3
Long-Term Deferred Tax Assets	0.01	0.01	0.02	0.01	0.01	0
Other Long-Term Assets	5.93	5.93	5.93	5.93	5.93	11.05
Total Assets	497.54	164.53	195.01	224.77	155.62	84.48
Accounts Payable	337.56	26.18	82.35	95.49	54.85	38.65
Accrued Expenses	-	0.37	0.22	0.25	0.22	0.34
Short-Term Debt	-	18.74	22.07	32.77	27.36	3.58
Current Portion of Long-Term Debt	65.07	34.44	2.81	32.87	1.75	-
Current Income Taxes Payable	-	0.23	2.67	1.43	0.25	0.49
Current Unearned Revenue	-	5.42	4.19	6.6	3.98	4.31
Other Current Liabilities	12.51	6.17	7.52	0.13	6.32	5.53
Total Current Liabilities	415.15	91.54	121.81	169.53	94.73	52.88
Long-Term Debt	36.25	33.35	26.82	14.33	25.97	-
Other Long-Term Liabilities	-	0	0	-	-	-
Total Liabilities	451.4	124.89	148.63	183.86	120.69	52.88
Common Stock	40	40	40	40	40	40
Retained Earnings	6.14	-0.36	6.38	0.91	-5.08	-8.4
Shareholders' Equity	46.14	39.64	46.38	40.91	34.93	31.6
Total Liabilities & Equity	497.54	164.53	195.01	224.77	155.62	84.48
Total Debt	101.32	86.52	51.7	79.97	55.08	3.58
Net Cash (Debt)	-95.31	-85.05	-49.74	-78.27	-54.52	-34.5
Net Cash Per Share	-2.37	-2.13	-1.27	-1.96	-1.36	-0.86
Filing Date Shares Outstanding	40.21	40	40	40	40	40
Total Common Shares Outstanding	40.21	40	40	40	40	40
Working Capital	42.67	32.3	35.6	26.01	29.78	-2.73
Book Value Per Share	1.15	0.99	1.16	1.02	0.87	0.79
Tangible Book Value	29.79	23.29	30.03	24.56	18.57	15.24
Tangible Book Value Per Share	0.74	0.58	0.75	0.61	0.46	0.38
Land	-	1.42	1.42	1.42	1.42	1.42
Buildings	-	2.46	2.46	2.46	2.46	2.46
Machinery	-	5.37	5.29	4.92	4.92	4.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.